Çѱ¹¹ÙÀÌ¿ÀÀǾàÇ°Çùȸ¿¡¼ ¾Ë·Áµå¸³´Ï´Ù.
¹Ì±¹¾àÀüÀ§¿øȸ (USP)¿¡¼ COVID-19 ´ëÀÀ¿¡ µµ¿òÀ» ÁÖ°íÀÚ ÃÖ±Ù ¸¶·ÃÇÑ °øÀÍ»ç¾÷¿¡ ´ëÇØ ¾È³»µå¸®°íÀÚ ÇÕ´Ï´Ù.
USP´Â COVID-19 °ü·Ã ¹é½Å, Ä¡·á¾à µîÀÇ °³¹ß ¾÷üµé¿¡ µµ¿òÀ» µå¸®°íÀÚ ÇöÀç ¹«·á ±â¼ú Áö¿ø ½Ã½ºÅÛÀ» ¿î¿µ Áß¿¡ ÀÖ½À´Ï´Ù.
±¸Ã¼ÀûÀÎ Áö¿ø »çÇ×Àº ¾Æ·¡ÀÇ ³»¿ëÀ» Æ÷ÇÔÇÕ´Ï´Ù.
- Á¦Á¶ Àü¹ÝÀ¸·Î ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ¸ç ±Û·Î¹ú ±ÔÁ¦ °¡À̵å¶óÀο¡ ºÎÇÕÇÏ´Â ½ÃÇè¹ý ¹× ÀýÂ÷¿¡ °üÇÑ Áö¿ø
- Á¦Á¶¿¡ »ç¿ëµÉ ¼ö ÀÖ´Â ºÎÇüÁ¦¿Í ¿øÀç·áÀÇ Á¶°Ç
- ºÐ¼®¹ý °³¹ß°ú validation, system suitability È®Àο¡ ÇÊ¿äÇÑ USP ½ºÅÄ´Ùµå Áö¿ø
- ¹Ì±¹¾àÀü°ú ±ÔÁ¦¿¡ ºÎÇÕÇÏ´Â ºÐ¼®¹ý °³¹ß ÀýÂ÷¿¡ °üÇÑ ±â¼ú Áö¿ø
»ý»ê ±Ô¸ð Áõ´ë, Ç°Áú °ü¸®¸¦ À§ÇÑ ½ÃÇè¹ý È®¸³ µî ±Þº¯ÇÏ´Â Á¦Á¶ ȯ°æ¿¡¼ ÀǾàÇ° Ç°Áú º¸ÁõÀ» À§ÇÑ ´Ù¾çÇÑ Áö¿øÀÌ °¡´ÉÇÏ´Ù°í ÇÕ´Ï´Ù.
»ó¼¼ ³»¿ëÀº ¾Æ·¡ÀÇ ¸µÅ© ¹× ÷ºÎ³»¿ë È®ÀÎ ºÎŹµå¸³´Ï´Ù.
Free Technical Assistance for Developers of COVID-19 Antiviral Drugs and Vaccines (¹Ù·Î°¡±â)
Free Access to USP-NF Standards Critical to the Development of Vaccines and Antivirals (¹Ù·Î°¡±â)
°ü½ÉÀÖ´Â ¾÷üÀÇ °æ¿ì, ¾Æ·¡ÀÇ ´ã´çÀÚ¿¡°Ô ¿¬¶ôÇÏ½Ã¸é µË´Ï´Ù.
Fouad Atouf, Ph.D.
Vice President, Global Biologics
fa@usp.org
+1-301-816-8365
÷ºÎ: USP-Support-covid19-antivirals-vaccines (032020) 1ºÎ. ³¡